Skip to Main Content

Author Details

Terry Hyslop
1994
240
58
PMIDPaper TitleJournal TitlePublished Year
36610386Modifiable Barriers and Facilitators for Breast Cancer Care: A Thematic Analysis of Patient and Provider Perspectives.2023
35909050Utility of a Rule-Based Algorithm in the Assessment of Standardized Reporting in PI-RADS.Acad Radiol2023
36411107Modifiable patient-reported factors associated with cancer-screening knowledge and participation in a community-based health assessment.American Journal of Surgery2023
36652667High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer.JCO Precis Oncol2023
36625746Surveillance Imaging after Primary Diagnosis of Ductal Carcinoma in Situ.2023
37436746Relative Burden of Cancer and Noncancer Mortality Among Long-Term Survivors of Breast, Prostate, and Colorectal Cancer in the US.JAMA Netw Open2023
34792814Disease characteristics and mortality among Asian women with breast cancer.Cancer2022
36179272Design and Evaluation of a Computational Phenotype to Identify Patients With Metastatic Breast Cancer Within the Electronic Health Record.JCO clinical cancer informatics2022
35509276Impact of Federal, State, and Local Housing Policies on Disparities in Cardiovascular Disease in Black/African American Men and Women: From Policy to Pathways to Biology.Frontiers in Cardiovascular Medicine2022
35426388Racial and Ethnic Disparities in Surgical Outcomes after Postmastectomy Breast Reconstruction.Journal of the American College of Surgeons2022
36332173IRONMAN: A Novel International Registry of Men With Advanced Prostate Cancer.JCO Glob Oncol2022
33026950Disparities at the Intersection of Race and Ethnicity: Examining Trends and Outcomes in Hispanic Women With Breast Cancer.JCO Oncology Practice2022
32657941A Novel Staging System for De Novo Metastatic Breast Cancer Refines Prognostic Estimates.Annals of Surgery2022
34989142Utilization of neoadjuvant chemotherapy in high-risk, node-negative early breast cancer.Cancer Medicine2022
35044810CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer.J Clin Oncol2022
34535683Author Correction: Cellphone enabled point-of-care assessment of breast tumor cytology and molecular HER2 expression from fine-needle aspirates.NPJ Breast Cancer2021
33705884Differential alternative RNA splicing and transcription events between tumors from African American and White patients in The Cancer Genome Atlas.Genomics2021
33854078Characterizing chronological accumulation of comorbidities in healthy veterans: a computational approach.Sci Rep2021
33951180A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.Cancer2021
33465699RNA splicing and aggregate gene expression differences in lung squamous cell carcinoma between patients of West African and European ancestry.Lung Cancer2021
34215753Cellphone enabled point-of-care assessment of breast tumor cytology and molecular HER2 expression from fine-needle aspirates.NPJ Breast Cancer2021
33826758Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program: A retrospective review of 90,000 women.Cancer2021
33206290Time to surgery among women treated with neoadjuvant systemic therapy and upfront surgery for breast cancer.Breast Cancer Research and Treatment2021
32875501Implementation and Impact of a Risk-Stratified Prostate Cancer Screening Algorithm as a Clinical Decision Support Tool in a Primary Care Network.Journal of General Internal Medicine2021
33175437Patient-reported causes of distress predict disparities in time to evaluation and time to treatment after breast cancer diagnosis.Cancer2021
32946012Treatment Patterns and Outcomes of Women with Breast Cancer and Supraclavicular Nodal Metastases.Annals of Surgical Oncology2021
32783550Mixed-Methods Study to Predict Upstaging of DCIS to Invasive Disease on Mammography.American Journal of Roentgenology2021
33001587Spatiotemporal strategies to identify aggressive biology in precancerous breast biopsies.2021
32770247Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line Chemotherapy.J Natl Cancer Inst2021
34794388Low-touch, team-based care for co-morbidity management in cancer patients: the ONE TEAM randomized controlled trial.BMC Family Practice2021
34885139Epigenetic Dysregulation of Imprinting and Triple-Negative Breast Cancer.Cancers2021
30312199Implications for Breast Cancer Restaging Based on the 8th Edition AJCC Staging Manual.Annals of Surgery2020
31909824Factors associated with biomedical research participation within community-based samples across 3 National Cancer Institute-designated cancer centers.Cancer2020
31960171Extent of axillary surgery in inflammatory breast cancer: a survival analysis of 3500 patients.Breast Cancer Research and Treatment2020
32125937Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor-Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance).J Clin Oncol2020
31678225Nodal Response to Neoadjuvant Chemotherapy Predicts Receipt of Radiation Therapy After Breast Cancer Diagnosis.International Journal of Radiation Oncology Biology Physics2020
32097289The Evolution of Breast Satisfaction and Well-Being after Breast Cancer: A Propensity-Matched Comparison to the Norm.Plastic and Reconstructive Surgery2020
31980967Breast cancer tumor histopathology, stage at presentation, and treatment in the extremes of age.Breast Cancer Research and Treatment2020
32211583A Case-Control Study Examining Disparities in Clinical Trial Participation Among Breast Surgical Oncology Patients.JNCI Cancer Spectrum2020
32468334Overall health at diagnosis predicts the risk of complications within the first year after breast cancer diagnosis.Breast Cancer Research and Treatment2020
32972968Auto-antibodies to p53 and the Subsequent Development of Colorectal Cancer in a U.S. Prospective Cohort Consortium.Cancer Epidemiol Biomarkers Prev2020
32856604Racial Differences in <i>Helicobacter pylori</i> CagA Sero-prevalence in a Consortium of Adult Cohorts in the United States.Cancer Epidemiol Biomarkers Prev2020
32856601Using Latent Class Modeling to Jointly Characterize Economic Stress and Multipollutant Exposure.Cancer Epidemiology Biomarkers and Prevention2020
32732224Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer.Clin Cancer Res2020
31356147Financial Costs and Burden Related to Decisions for Breast Cancer Surgery.J Oncol Pract2019
31644911The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer.Cell Rep2019
31718588Advanced neoplasia in Veterans at screening colonoscopy using the National Cancer Institute Risk Assessment Tool.BMC Cancer2019
31703083Breast cancer in Tanzanian, black American, and white American women: An assessment of prognostic and predictive features, including tumor infiltrating lymphocytes.PLoS ONE2019
30296434Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States.Gastroenterology2019
30635829Adjuvant Chemotherapy Improves Survival Following Resection of Locally Advanced Rectal Cancer with Pathologic Complete Response.Journal of Gastrointestinal Surgery2019
  • 1 - 50 of 240

Recommended Authors

Collaborators

Thomas Jefferson University Hospital
Co-authored papers 15
Walter Reed National Military Medical Center
Co-authored papers 8
Co-authored papers 6
Columbia University Irving Medical Center
Co-authored papers 6
Memorial Sloan Kettering Cancer Center, USA American Society of Clinical Oncology
Co-authored papers 5
South China University of Technology
Co-authored papers 5
Co-authored papers 5
Dana-Farber Cancer Institute
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 3
Co-authored papers 3
Duke University
Co-authored papers 3
Thomas Jefferson University
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Co-authored papers 3
Baylor College of Medicine
Co-authored papers 3
Co-authored papers 3
Vanderbilt University Medical Center
Co-authored papers 3
Weill Cornell School of Medicine
Co-authored papers 3
Co-authored papers 3
University of Chicago
Co-authored papers 3
National Cancer Institute
Co-authored papers 2
Dana-Farber Cancer Institute
Co-authored papers 2
Lineberger Cancer Center, University of North Carolina
Co-authored papers 2
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers 2
Co-authored papers 2
Duke University
Co-authored papers 2